Birdwatch Note
2023-07-17 15:30:41 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
En efecto, el término correcto no sería "enferma crónica" sino "paciente o sujeto sometido a medicación crónica" o "paciente crónico" https://aprimariavsg.com/es/tramites_administrativos/medicacion-cronica/ Teniendo en cuenta efectos secundarios a largo plazo sí podríamos hablar de "enfermos crónicos" por el potencial riesgo cardiovascular. http://www.sagij.org.ar/index.php/publicaciones/revista-sagij/ano-2017-n-2/143-profesionales/publicaciones/revista-numero-actual/ano-2017-n-2/1485-tratamiento-hormonal-cruzado-de-personas-trans-y-sus-complicaciones
Written by 56879B596EFF172372FF56B632C5B296C7416B54FAE55CE8AA8853632EB50D6D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1680906044002713600
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1680963240413495297
- noteId - 1680963240413495297
- participantId -
- noteAuthorParticipantId - 56879B596EFF172372FF56B632C5B296C7416B54FAE55CE8AA8853632EB50D6D Participant Details
- createdAtMillis - 1689607841958
- tweetId - 1680906044002713600
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- En efecto, el término correcto no sería "enferma crónica" sino "paciente o sujeto sometido a medicación crónica" o "paciente crónico" https://aprimariavsg.com/es/tramites_administrativos/medicacion-cronica/ Teniendo en cuenta efectos secundarios a largo plazo sí podríamos hablar de "enfermos crónicos" por el potencial riesgo cardiovascular. http://www.sagij.org.ar/index.php/publicaciones/revista-sagij/ano-2017-n-2/143-profesionales/publicaciones/revista-numero-actual/ano-2017-n-2/1485-tratamiento-hormonal-cruzado-de-personas-trans-y-sus-complicaciones
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-07-17 15:30:41 UTC (1689607841958) |
1969-12-31 23:59:59 UTC (-1) |
2023-07-18 02:11:03 UTC (1689646263914) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-07-17 19:13:08 -0500 | Rating Details | |
2023-07-17 18:57:34 -0500 | Rating Details | |
2023-07-17 18:42:03 -0500 | Rating Details | |
2023-07-17 18:40:37 -0500 | Rating Details | |
2023-07-17 17:44:37 -0500 | Rating Details | |
2023-07-17 17:43:00 -0500 | Rating Details | |
2023-07-17 17:27:12 -0500 | Rating Details | |
2023-07-17 17:20:11 -0500 | Rating Details | |
2023-07-17 17:03:43 -0500 | Rating Details | |
2023-07-17 16:19:09 -0500 | Rating Details | |
2023-07-17 16:03:29 -0500 | Rating Details | |
2023-07-17 15:56:17 -0500 | Rating Details | |
2023-07-17 15:48:42 -0500 | Rating Details | |
2023-07-17 15:47:25 -0500 | Rating Details | |
2023-07-17 15:32:06 -0500 | Rating Details | |
2023-07-17 15:05:08 -0500 | Rating Details | |
2023-07-17 15:01:09 -0500 | Rating Details | |
2023-07-17 14:43:57 -0500 | Rating Details | |
2023-07-17 14:34:46 -0500 | Rating Details | |
2023-07-17 14:29:04 -0500 | Rating Details | |
2023-07-17 14:24:02 -0500 | Rating Details | |
2023-07-17 13:59:08 -0500 | Rating Details | |
2023-07-17 13:51:29 -0500 | Rating Details | |
2023-07-17 13:49:01 -0500 | Rating Details | |
2023-07-17 13:35:33 -0500 | Rating Details | |
2023-07-17 13:33:30 -0500 | Rating Details | |
2023-07-17 13:31:12 -0500 | Rating Details | |
2023-07-17 13:29:10 -0500 | Rating Details | |
2023-07-17 13:21:07 -0500 | Rating Details | |
2023-07-17 13:15:56 -0500 | Rating Details | |
2023-07-17 13:13:25 -0500 | Rating Details | |
2023-07-17 13:09:52 -0500 | Rating Details | |
2023-07-17 13:09:31 -0500 | Rating Details | |
2023-07-17 13:04:27 -0500 | Rating Details | |
2023-07-17 13:00:14 -0500 | Rating Details | |
2023-07-17 12:50:15 -0500 | Rating Details | |
2023-07-17 12:49:48 -0500 | Rating Details | |
2023-07-17 12:46:39 -0500 | Rating Details | |
2023-07-17 12:40:19 -0500 | Rating Details | |
2023-07-17 12:33:38 -0500 | Rating Details | |
2023-07-17 12:27:59 -0500 | Rating Details | |
2023-07-17 12:20:36 -0500 | Rating Details | |
2023-07-17 12:01:49 -0500 | Rating Details | |
2023-07-17 12:01:16 -0500 | Rating Details | |
2023-07-17 11:58:55 -0500 | Rating Details | |
2023-07-17 11:54:37 -0500 | Rating Details | |
2023-07-17 11:48:43 -0500 | Rating Details | |
2023-07-17 11:45:11 -0500 | Rating Details | |
2023-07-17 11:41:48 -0500 | Rating Details | |
2023-07-17 11:34:47 -0500 | Rating Details | |
2023-07-17 11:33:52 -0500 | Rating Details | |
2023-07-17 11:32:35 -0500 | Rating Details | |
2023-07-17 11:28:53 -0500 | Rating Details | |
2023-07-17 11:13:34 -0500 | Rating Details | |
2023-07-17 11:12:55 -0500 | Rating Details | |
2023-07-17 11:04:56 -0500 | Rating Details | |
2023-07-17 11:02:23 -0500 | Rating Details | |
2023-07-17 10:52:38 -0500 | Rating Details | |
2023-07-17 10:48:21 -0500 | Rating Details | |
2023-07-17 10:46:26 -0500 | Rating Details | |
2023-07-17 10:42:10 -0500 | Rating Details | |
2023-07-18 12:57:23 -0500 | Rating Details | |
2023-07-18 12:53:19 -0500 | Rating Details | |
2023-07-18 11:59:04 -0500 | Rating Details | |
2023-07-18 11:40:21 -0500 | Rating Details | |
2023-07-18 10:52:48 -0500 | Rating Details | |
2023-07-18 09:50:40 -0500 | Rating Details | |
2023-07-18 09:32:17 -0500 | Rating Details | |
2023-07-18 09:20:52 -0500 | Rating Details | |
2023-07-18 08:58:29 -0500 | Rating Details | |
2023-07-18 08:22:41 -0500 | Rating Details | |
2023-07-18 07:57:35 -0500 | Rating Details | |
2023-07-18 07:08:10 -0500 | Rating Details | |
2023-07-18 06:07:14 -0500 | Rating Details | |
2023-07-18 05:45:06 -0500 | Rating Details | |
2023-07-18 05:23:30 -0500 | Rating Details | |
2023-07-18 05:20:48 -0500 | Rating Details | |
2023-07-18 04:59:51 -0500 | Rating Details | |
2023-07-18 04:28:39 -0500 | Rating Details | |
2023-07-18 04:12:50 -0500 | Rating Details | |
2023-07-18 02:33:33 -0500 | Rating Details | |
2023-07-18 02:32:23 -0500 | Rating Details | |
2023-07-18 01:51:39 -0500 | Rating Details | |
2023-07-18 01:42:13 -0500 | Rating Details | |
2023-07-18 01:41:30 -0500 | Rating Details | |
2023-07-18 01:17:38 -0500 | Rating Details | |
2023-07-18 01:06:29 -0500 | Rating Details | |
2023-07-17 23:55:44 -0500 | Rating Details | |
2023-07-17 23:47:24 -0500 | Rating Details | |
2023-07-17 20:10:11 -0500 | Rating Details | |
2023-07-17 20:01:40 -0500 | Rating Details | |
2023-07-19 03:25:53 -0500 | Rating Details | |
2023-07-21 07:38:07 -0500 | Rating Details | |
2023-07-21 07:17:00 -0500 | Rating Details | |
2023-07-24 10:23:43 -0500 | Rating Details | |
2023-09-07 16:56:40 -0500 | Rating Details |